Opioid-related neurocognitive symptoms among patients on long-term opioid therapy were most prevalent during the course of therapy.

A new study led by researchers at the Harvard Pilgrim Health Care Institute found that a 2019 Medicare opioid safety policy showed initial reductions in opioid prescribing to high-risk populations.

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

Journavx has been cleared for adults with moderate to acute pain, which is usually short-term and often resulting from surgery or an injury. Opioids and ... M.D., acting director of the FDA ...

is intended for short-term pain relief following surgery or injury, the Associated Press reported. While it provides a long-awaited alternative to opioids and over-the-counter painkillers like ...